Connect with us

Technology

AIM Vaccine Integrates DeepSeek: Innovative Technology and Growth Potential Support Valuation Upside

Published

on

HONG KONG, Feb. 24, 2025 /PRNewswire/ — AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on February 23, 2025, announced that the company is fully deploying the DeepSeek large model and promoting the application of DeepSeek R1 version across all business scenarios through localized strategies, achieving cost reduction, quality improvement, and efficiency enhancement throughout the vaccine lifecycle. This move opens up greater imagination for AIM Vaccine’s value growth.

As recently analyzed in a research report by FOSUN International Securities, “For investors looking to enter the vaccine industry, AIM Vaccine integrates innovative technology, industry leadership, and growth potential, making it an attractive investment choice.” The report believes that the company’s valuation has significant upside potential, initiating coverage with a “Buy” rating and a target price of HKD 11.

According to AIM Vaccine’s announcement, a series of actions in the much-anticipated “AI + Vaccine” R&D system will bring disruptive changes. AIM will leverage the DeepSeek large model to obtain higher quality vaccine candidates through processes such as discovery, design, and manufacturing. By integrating multi-source heterogeneous data from various biological information databases and merging pre-trained protein language models with graph neural network architectures, it is expected to achieve intelligent screening of antigen targets and dynamic analysis of conserved regions. Additionally, by accessing real-time mutation monitoring data streams and using long and short-term memory networks to predict future pathogen mutation directions, the analysis of conserved regions and the prediction of broad-spectrum antigen epitopes will be conducted. AIM will also utilize DeepSeek in conjunction with generative models and deep learning techniques to optimize mRNA vaccine sequence design and stability. By predicting mRNA secondary structure and intelligently designing efficient component combinations based on the host cells’ codon bias characteristics, the stability and translation efficiency of mRNA can be improved, generating optimal sequences. Furthermore, AIM is exploring the use of DeepSeek’s AI framework to optimize process parameters to enhance antigen yield and quality.

In clinical aspects, the comprehensive deployment of DeepSeek R1 version will be fully integrated with clinical trial management systems, electronic data capture (EDC) systems, central randomization systems, drug safety monitoring systems, and laboratory management systems, driving the intelligent realization of the entire chain from data acquisition, analysis to decision-making in vaccine clinical trials. This will shorten clinical trial cycles while enhancing data accuracy and compliance, allowing researchers to focus more on core areas such as project advancement, quality assessment, ethical judgment, and human care, providing technical support for the rapid market launch of vaccines. This will significantly improve the efficiency and quality of clinical research while reducing costs.

In production and quality control, the full deployment of the DeepSeek R1 version will be integrated with MES systems, LIMS systems, and SCADA systems, achieving deep learning on production, inspection data, and real-time monitoring data. This will construct predictive models for production and quality inspection management, optimize production processes, enhance production efficiency, shorten production cycles, and reduce energy consumption. By using AI to analyze relevant quality data from production and inspection, potential risks can be identified, enabling preventive quality control and ensuring high-standard compliance for every batch of vaccines, further enhancing the stability, reliability, and consistency of vaccine quality.

Due to the optimistic market attitude towards the technological innovations sparked by DeepSeek, Hong Kong stocks have outperformed global peers over the past month. Among them, DeepSeek concept stocks have become a market hotspot, especially the combination of biomedicine and AI, which is a key sector for market exploration.

Currently, international institutions such as Goldman Sachs, UBS, and Bank of America are optimistic about Chinese assets. HSBC Global Private Banking and Wealth Management’s Chief Investment Officer for China, Kuang Zheng, publicly stated to the media that the success of DeepSeek could become a catalyst for further promoting technological innovation in private enterprises in China, which is expected to boost investor confidence in the Chinese stock market. Therefore, some analysts believe that AIM Vaccine, as an industry leader, will see its original technological innovation advantages and industry-leading position accelerated with the support of DeepSeek.

FOSUN International Securities’ research report suggests that AIM Vaccine’s valuation is lower than that of major Chinese competitors and global vaccine giants, indicating an overreaction by the market to its short-term losses and low expectations for growth or profitability. The report predicts that from 2024 to 2027, AIM Vaccine’s revenue compound annual growth rate (CAGR) will reach 47%, with a projected breakeven in 2025 and net profit expected to exceed RMB 1.52 billion by 2027.

Looking ahead, according to the analysis in the FOSUN International Securities research report, AIM Vaccine, as a comprehensive leader in the Chinese vaccine market, demonstrates significant long-term growth potential based on its differentiated product portfolio, strong R&D and production capabilities, and clear global expansion strategy.

As the first vaccine company to propose the goal of “AI + Vaccine Intelligent Enterprise,” AIM’s comprehensive deployment of the DeepSeek large model is expected to lead in the “AI + Vaccine” innovation track. As analyzed in the FOSUN International Securities research report, with the launch of multiple high-value products in the coming years, the company’s revenue and profitability are expected to rebound strongly, driving a significant increase in its valuation.

View original content:https://www.prnewswire.com/apac/news-releases/aim-vaccine-integrates-deepseek-innovative-technology-and-growth-potential-support-valuation-upside-302382968.html

SOURCE AIM Vaccine

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Danish Publisher Automates Digital Textbook Delivery with Integrated WooCommerce-Webdoxx Solution

Published

on

By

Danish educational publisher eliminates manual processing errors and delivers instant access to more than 20 digital learning products

LONDON, May 3, 2026 /PRNewswire-PRWeb/ — Forlaget 94, a Danish educational publisher serving commercial colleges and vocational schools since 1994, has transformed its digital textbook distribution by implementing a fully automated WooCommerce-Webdoxx solution.

“Using the Webdoxx-WooCommerce integration we have achieved full automation of order processing, fewer errors, and happier customers,” Tom Gertsen, IT Manager at Forlaget 94

Previously, Forlaget 94 relied on manual processes to distribute digital textbooks to customers. As demand for online educational materials grew, the publisher required a faster, more reliable way to manage orders, provision access, and reduce the risk of administrative errors.

Through its integration of WooCommerce with Webdoxx, Forlaget 94 now runs more than 20 educational products through a 100% automated workflow. The solution automatically processes customer orders and provides instant access to purchased digital textbooks, improving the experience for both customers and internal teams.

“The result is full automation of order processing, fewer errors, and happier customers,” said Tom Gertsen, IT Manager at Forlaget 94 and architect behind the WooCommerce-Webdoxx integration. The automated system has enabled Forlaget 94 to eliminate manual errors, accelerate customer processing, and increase customer satisfaction through immediate access provisioning. The implementation demonstrates how educational publishers can modernize digital content delivery while maintaining secure, managed access to learning materials.

Webdoxx, a service created and managed by Drumlin Security Ltd, provides online DRM and managed document delivery services for publishers, educational organizations, institutions, and commercial content providers.

About Forlaget 94

Forlaget 94 is a Danish educational publisher established in 1994, providing educational products for commercial colleges and vocational schools.

About Webdoxx

Webdoxx is an online DRM and managed document delivery service created and managed by Drumlin Security Ltd. The platform supports secure access to digital publications and documents across a range of sectors, including education, healthcare, government, finance, and publishing.

Media Contact

Mike de Smith, Drumlin Security Ltd, 44 7768404712, info@drumlinsecurity.com, https://www.drumlinsecurity.com/

View original content to download multimedia:https://www.prweb.com/releases/danish-publisher-automates-digital-textbook-delivery-with-integrated-woocommerce-webdoxx-solution-302759942.html

SOURCE Forlaget 94

Continue Reading

Technology

139th Canton Fair Phase 3 Advances Toward a Better Life with New and Strengthened Product Zones

Published

on

By

GUANGZHOU, China, May 3, 2026 /PRNewswire/ — The 139th China Import and Export Fair (Canton Fair) has rolled out nine newly established product zones. Phase 3 features an expanded and upgraded Intelligent Healthcare zone and the inaugural presentation of a Functional & Technical Fabrics zone.

The upgraded Intelligent Healthcare zone brings together 50 companies presenting a full spectrum of intelligent medical solutions, spanning AI-powered diagnostics, surgical robotics, and next‑generation eldercare technologies. Exhibits highlight how medical devices are becoming smaller, more precise, and increasingly non‑invasive. Capsule endoscopy systems demonstrate how gastrointestinal screening can be completed without discomfort, while AI‑enabled traditional Chinese medicine analyzers compress the inspection and inquiry process into minutes. Wearable glucose monitors make chronic disease management easier and more convenient.

Robotic technologies play a prominent role as well. Endoscopic and orthopedic surgical robots showcase enhanced precision through integrated human‑machine coordination, while bionic prosthetic hands use non‑invasive myoelectric sensing to independently control each finger. Intelligent rehabilitation systems, including lower‑limb exoskeletons and hand‑training devices, provide consistent support for patients recovering mobility. Companion‑style eldercare robots, equipped with monitoring and telemedicine functions, signal the rise of integrated home‑based health services.

The debuting Functional & Technical Fabrics zone highlights how the traditional textile industry is moving toward higher-end and smarter products. Exhibitors present materials that combine multi‑layered performance with intelligent responsiveness. Textiles featuring temperature‑regulating fibers, phase‑change materials, and light‑ or heat‑sensitive color‑shifting effects illustrate how fabrics are evolving into adaptive platforms capable of responding to environmental conditions.

Sustainability emerges as a defining theme. Bio‑based fibers, degradable films, recycled polyester, and organic cotton reflect a shift from isolated eco‑products toward full‑chain green manufacturing. High‑performance outdoor and protective applications further shape the narrative. Materials engineered for waterproof breathability, UV resistance, flame retardancy, and long‑term durability address rising demand across sportswear, professional protection, and medical environments. Smart textiles with embedded health‑monitoring modules demonstrate how apparel is beginning to function as a continuous wellness interface.

Both technology‑driven healthcare and advanced textiles are converging around a shared pursuit of a better life. As these advancements continue to evolve, they reflect a manufacturing landscape increasingly shaped by innovation, resilience, and a commitment to improving everyday living.

For pre-registration, please click: https://buyer.cantonfair.org.cn/register/buyer/email?source_type=16

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/139th-canton-fair-phase-3-advances-toward-a-better-life-with-new-and-strengthened-product-zones-302760704.html

SOURCE Canton Fair

Continue Reading

Technology

CupidFeel Insights Show How Shared Interests Affect Initial Connection Outcomes

Published

on

By

New behavioral insights from CupidFeel offer a carefully considered look at how shared interests influence whether an initial connection on a dating platform is sustained or abandoned in those first critical exchanges.

GIBRALTAR, May 3, 2026 /PRNewswire-PRWeb/ — The findings by CupidFeel are not dramatic, but they are telling. People who referenced a shared interest — whether a genre of music, a type of cuisine, a sport, a creative practice, or even a shared discomfort with small talk — within the first few exchanges of a new conversation were found to be measurably more likely to continue that conversation beyond the initial contact window. The effect was not uniform across all interest categories; certain types of shared interest appeared to carry more relational weight than others.

It was also observed by CupidFeel that the timing of when shared interests entered a conversation mattered. Connections where common ground was discovered organically — through the natural flow of exchange rather than prompted by a profile field or a direct question — showed stronger indicators of sustained interest. The discovery, in other words, carried more meaning when it felt like something found rather than something declared.

Among the most quietly striking findings in the CupidFeel data was the role of specificity. Broad shared categories — “we both like travel,” “we both enjoy cooking” — were associated with polite, often brief exchanges that rarely extended past pleasantries. But when specificity entered the picture — when one person mentioned a particular documentary that had stayed with them, or a city they had visited and could not stop thinking about — the conversational energy shifted. Something opened up.

In a CupidFeel review of trends in profile engagements, those whose profiles reflected specific, idiosyncratic interests — rather than broadly appealing ones — also showed higher rates of receiving first messages, a finding that runs gently counter to the instinct many people have to present themselves in the most universally appealing terms possible.

What seemed to matter most was not the quantity of overlap but whether the overlap that existed was felt — whether it produced a sense of being seen in some particular, non-generic way. A CupidFeel review of early conversation patterns suggests that a single deeply resonant shared interest may be more generative for early connection than a long list of surface-level commonalities that, taken together, feel more like a demographic profile than a person.

About CupidFeel

CupidFeel is an online dating platform built around the belief that meaningful connections begin with emotional honesty and the willingness to let a conversation go somewhere real. It came into being for people who are less interested in the mechanics of dating and more drawn to the possibility of something that feels grounded — exchanges that move at their own pace, guided by genuine curiosity rather than performance.

A CupidFeel review of its own design principles returns consistently to the same question: what does it take for a first message to feel like it might be worth the journey? The platform makes room for the kind of interaction that doesn’t always have a clear destination but feels, from the first exchange, like something real. CupidFeel is a place where the unexpected is not something to be managed, but something to be welcomed.

Media Contact

Timothy Albers, CupidFeel, 1 14845691657, smm@cupidfeel.com, https://cupidfeel.com/

View original content:https://www.prweb.com/releases/cupidfeel-insights-show-how-shared-interests-affect-initial-connection-outcomes-302759951.html

SOURCE CupidFeel

Continue Reading

Trending